Back to Browse Journals » OncoTargets and Therapy » Volume 3

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab

Authors Carmen Diana Schweighofer, Clemens-Martin Wendtner

Published Date March 2010 Volume 2010:3 Pages 53—67

DOI http://dx.doi.org/10.2147/OTT.S3099

Published 30 March 2010

Carmen Diana Schweighofer1, Clemens-Martin Wendtner2

1Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA; 2Department of Internal Medicine I, University of Cologne, Cologne, Germany

Abstract: The CD52-targeting antibody alemtuzumab is established in clinical practice with convincing activity in relapsed and refractory chronic lymphocytic leukemia (CLL), particularly in patients with high-risk features and adverse prognosis. In the CAM307 study alemtuzumab was tested and finally approved as a first-line single agent, even though the hurdle with chlorambucil as the contender was not set very high. Within clinical trials, the drug demonstrated an excellent ability to eliminate minimal residual disease in blood and bone marrow, which has been correlated with a corresponding survival advantage in patients. However, in the maintenance setting, infectious complications due to severe T cell suppression have been highlighted and do not allow clinicans to use alemtuzumab outside of clinical trials. This review discusses potential therapeutic niches and future applications of alemtuzumab with a focus on CLL front-line treatment.
Keywords: CLL, alemtuzumab, Campath, front-line, first-line treatment

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Femtosecond laser versus mechanical microkeratome-assisted flap creation for LASIK: a prospective, randomized, paired-eye study

Pajic B, Vastardis I, Pajic-Eggspuehler B, Gatzioufas Z, Hafezi F

Clinical Ophthalmology 2014, 8:1883-1889

Published Date: 22 September 2014

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes

Cosco D, Federico C, Maiuolo J, Bulotta S, Molinaro R, Paolino D, Tassone P, Fresta M

International Journal of Nanomedicine 2014, 9:2359-2372

Published Date: 15 May 2014

Antidepressants in primary care: patients’ experiences, perceptions, self-efficacy beliefs, and nonadherence

Wouters H, Bouvy ML, Van Geffen ECG, Gardarsdottir H, Stiggelbout AM, Van Dijk L

Patient Preference and Adherence 2014, 8:179-190

Published Date: 10 February 2014

Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors

Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM

International Journal of Nanomedicine 2014, 9:273-287

Published Date: 3 January 2014

Physical performance in recently aged adults after 6 weeks traditional Thai dance: a randomized controlled trial

Janyacharoen T, Laophosri M, Kanpittaya J, Auvichayapat P, Sawanyawisuth K

Clinical Interventions in Aging 2013, 8:855-859

Published Date: 24 July 2013

Poor correlation between intracranial pressure and intraocular pressure by hand-held tonometry

Golan S, Kurtz S, Mezad-Koursh D, Waisbourd M, Kesler A, Halpern P

Clinical Ophthalmology 2013, 7:1083-1087

Published Date: 10 June 2013

A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations

Karavana SY, Gökçe EH, Rençber S, Özbal S, Pekçetin Ç, Güneri P, Ertan G

International Journal of Nanomedicine 2012, 7:5693-5704

Published Date: 9 November 2012

Clinical utility of ultrasound guidance for intra-articular knee injections: a review

Berkoff DJ, Miller LE, Block JE

Clinical Interventions in Aging 2012, 7:89-95

Published Date: 20 March 2012